Rare diseases
Investigational molecules
Locations
Study on Isatuximab, Pomalidomide, Dexamethasone, and Carfilzomib for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy on Nivolumab and Tisagenlecleucel for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia After Treatment Loss
FranceStudy on Izokibep for Patients with Non-infectious Uveitis
AustriaStudy of Acalabrutinib for Patients with Waldenström Macroglobulinemia
FranceStudy of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors
FranceStudy of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study
BelgiumStudy on the Effects of Ferric Derisomaltose on Cognitive Function in Heart Failure Patients with Iron Deficiency
GermanyStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
AustriaStudy of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor
AustriaStudy on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery
FranceStudy on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients
SpainStudy on Deferiprone for Preventing Secondary Degeneration in Stroke Patients
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
